148 related articles for article (PubMed ID: 1352999)
1. CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse.
Banki CM; Karmacsi L; Bissette G; Nemeroff CB
Eur Neuropsychopharmacol; 1992 Jun; 2(2):107-13. PubMed ID: 1352999
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid neuropeptides in mood disorder and dementia.
Banki CM; Karmacsi L; Bissette G; Nemeroff CB
J Affect Disord; 1992 May; 25(1):39-45. PubMed ID: 1352520
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment.
Heuser I; Bissette G; Dettling M; Schweiger U; Gotthardt U; Schmider J; Lammers CH; Nemeroff CB; Holsboer F
Depress Anxiety; 1998; 8(2):71-9. PubMed ID: 9784981
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion.
Kling MA; Rubinow DR; Doran AR; Roy A; Davis CL; Calabrese JR; Nieman LK; Post RM; Chrousos GP; Gold PW
Neuroendocrinology; 1993 Jan; 57(1):79-88. PubMed ID: 8097579
[TBL] [Abstract][Full Text] [Related]
5. CSF corticotropin releasing hormone, somatostatin, and thyrotropin releasing hormone in schizophrenia.
Banki CM; Karmacsi L; Bissette G; Nemeroff CB
Psychiatry Res; 1992 Jul; 43(1):13-21. PubMed ID: 1359593
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin.
Nemeroff CB; Bissette G; Akil H; Fink M
Br J Psychiatry; 1991 Jan; 158():59-63. PubMed ID: 1673078
[TBL] [Abstract][Full Text] [Related]
7. Association of fluoxetine treatment with reductions in CSF concentrations of corticotropin-releasing hormone and arginine vasopressin in patients with major depression.
De Bellis MD; Gold PW; Geracioti TD; Listwak SJ; Kling MA
Am J Psychiatry; 1993 Apr; 150(4):656-7. PubMed ID: 8465888
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid levels of somatostatin, corticotropin-releasing hormone and corticotropin in alcoholism.
Roy A; DeJong J; Gold P; Rubinow D; Adinoff B; Ravitz B; Waxman R; Linnoila M
Acta Psychiatr Scand; 1990 Jul; 82(1):44-8. PubMed ID: 1975969
[TBL] [Abstract][Full Text] [Related]
9. A follow up study of suicide attempters: increase of CSF-somatostatin but no change in CSF-CRH.
Westrin A; Ekman R; Regnéll G; Träskman-Bendz L
Eur Neuropsychopharmacol; 2001 Apr; 11(2):135-43. PubMed ID: 11313159
[TBL] [Abstract][Full Text] [Related]
10. Monoamine metabolites, corticotropin releasing factor and somatostatin as CSF markers in depressed patients.
Widerlöv E; Bissette G; Nemeroff CB
J Affect Disord; 1988; 14(2):99-107. PubMed ID: 2452842
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid levels of glutamate and corticotropin releasing hormone in major depression before and after treatment.
Garakani A; Martinez JM; Yehuda R; Gorman JM
J Affect Disord; 2013 Apr; 146(2):262-5. PubMed ID: 22840611
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid immunoreactive corticotropin-releasing hormone and adrenocorticotropin secretion in Cushing's disease and major depression: potential clinical implications.
Kling MA; Roy A; Doran AR; Calabrese JR; Rubinow DR; Whitfield HJ; May C; Post RM; Chrousos GP; Gold PW
J Clin Endocrinol Metab; 1991 Feb; 72(2):260-71. PubMed ID: 1846869
[TBL] [Abstract][Full Text] [Related]
13. CSF somatostatin in anorexia nervosa and bulimia: relationship to the hypothalamic pituitary-adrenal cortical axis.
Kaye WH; Rubinow D; Gwirtsman HE; George DT; Jimerson DC; Gold PW
Psychoneuroendocrinology; 1988; 13(3):265-72. PubMed ID: 2900533
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid corticotropin-releasing hormone, vasopressin, and oxytocin concentrations in treated patients with major depression and controls.
Pitts AF; Samuelson SD; Meller WH; Bissette G; Nemeroff CB; Kathol RG
Biol Psychiatry; 1995 Sep; 38(5):330-5. PubMed ID: 7495928
[No Abstract] [Full Text] [Related]
15. CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures.
Molchan SE; Hill JL; Martinez RA; Lawlor BA; Mellow AM; Rubinow DR; Bissette G; Nemeroff CB; Sunderland T
Psychoneuroendocrinology; 1993; 18(7):509-19. PubMed ID: 7903467
[TBL] [Abstract][Full Text] [Related]
16. CSF corticotropin-releasing hormone in depressed patients and normal control subjects.
Roy A; Pickar D; Paul S; Doran A; Chrousos GP; Gold PW
Am J Psychiatry; 1987 May; 144(5):641-5. PubMed ID: 3495188
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid neuropeptides in dementia.
Banki CM; Karmacsi L; Bissette G; Nemeroff CB
Biol Psychiatry; 1992 Sep; 32(5):452-6. PubMed ID: 1486150
[TBL] [Abstract][Full Text] [Related]
18. Relationship of cognitive factors to CSF corticotropin-releasing hormone in depression.
De Jong JA; Roy A
Am J Psychiatry; 1990 Mar; 147(3):350-2. PubMed ID: 2309955
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid corticotropin-releasing hormone in depression: relationship to noradrenergic function.
Roy A; Pickar D; Linnoila M; Chrousos GP; Gold PW
Psychiatry Res; 1987 Mar; 20(3):229-37. PubMed ID: 3495811
[TBL] [Abstract][Full Text] [Related]
20. Serial cerebrospinal fluid corticotropin-releasing hormone concentrations in healthy and depressed humans.
Geracioti TD; Orth DN; Ekhator NN; Blumenkopf B; Loosen PT
J Clin Endocrinol Metab; 1992 Jun; 74(6):1325-30. PubMed ID: 1317385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
